AIM IMMUNOTECH INC. Marketable Securities
AIM IMMUNOTECH INC. (AIM) had Marketable Securities of $64.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-08-07
- 2026-06-30: Marketable Securities $64.00K.
- 2026-03-31: Marketable Securities $63.00K.
- 2025-12-31: Marketable Securities $62.00K.
- 2025-09-30: Marketable Securities $62.00K.
| Period end | Marketable Securities |
|---|---|
| 2026-06-30 | $64.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $63.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $62.00K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $62.00K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $359.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.35M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.28M 10-K · filed 2026-03-27 |
| 2024-06-30 | $6.51M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $7.65M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $7.63M 10-Q · filed 2024-08-14 |
| 2023-09-30 | $7.17M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $7.36M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.45M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.14M 10-K · filed 2024-04-01 |
| 2022-09-30 | $6.99M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.32M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $15.55M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $16.18M 10-K · filed 2023-03-31 |
| 2021-09-30 | $16.31M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $16.14M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $14.83M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $15.88M 10-K · filed 2022-03-31 |
| 2020-09-30 | $15.98M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.40M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $22.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $7.31M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |